Prostate cancer trials in Lithuania
8 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Where
- Kaunas, Vilnius
- Age
- 18 years and over
- People
- 1,314 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00 - No phaseTaking peopleA Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
- Where
- Many Locations
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Bayer
See details and how to joinNCT07344779 - No phaseTaking peoplePredictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- Where
- Kaunas
- Age
- 18 years and over
- People
- 70
- Run by
- Lithuanian University of Health Sciences
See details and how to joinNCT07863986 - No phaseNot yet taking people in LithuaniaEffects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment Effectiveness
- Where
- Kaunas
- Age
- 18 years and over
- People
- 10
- Run by
- Lithuanian University of Health Sciences
See details and how to joinNCT07656337 - No phaseTaking peoplePrognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
- Where
- Kaunas
- Age
- 18 years and over
- People
- 500
- Run by
- Lithuanian University of Health Sciences
See details and how to joinNCT07516886 - Phase 2Not yet taking people in LithuaniaA Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer
- Where
- Kaunas, Klaipeda, Vilnius
- Age
- 18 years to 85 years
- People
- 40
- Run by
- Antev Ltd.
See details and how to joinNCT07457164 · EU 2023-509255-14-01 - No phaseEnrolling by invitationProstate Cancer Awareness and Initiative for Screening in the European Union
- Where
- Vilnius
- Age
- 50 years to 69 years
- People
- 20,000 worldwide
- Run by
- European Association of Urology Research Foundation
See details and how to joinNCT06424275 - No phaseEnrolling by invitationCharacterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage
- Where
- Kaunas
- Age
- 18 years to 100 years
- People
- 400
- Run by
- Edgaras Burzinskis
See details and how to joinNCT06505356